0001104659-21-153685.txt : 20211227 0001104659-21-153685.hdr.sgml : 20211227 20211227205807 ACCESSION NUMBER: 0001104659-21-153685 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211222 FILED AS OF DATE: 20211227 DATE AS OF CHANGE: 20211227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SBLENDORIO GLENN CENTRAL INDEX KEY: 0001277478 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 211521928 MAIL ADDRESS: STREET 1: 3 TIMES SQAURE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IVERIC bio, Inc. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208185347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 PENN PLAZA STREET 2: SUITE 2372 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-845-8200 MAIL ADDRESS: STREET 1: 5 PENN PLAZA STREET 2: SUITE 2372 CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: Ophthotech Corp. DATE OF NAME CHANGE: 20070828 4 1 tm2136407-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-12-22 0 0001410939 IVERIC bio, Inc. ISEE 0001277478 SBLENDORIO GLENN C/O IVERIC BIO, INC. 5 PENN PLAZA, SUITE 2372 NEW YORK, NY 10001 1 1 0 0 CEO Common Stock 2021-12-22 4 M 0 22163 1.45 A 361296 D Common Stock 2021-12-22 4 S 0 22163 16.5042 D 339133 D Common Stock 2021-12-23 4 M 0 22608 1.45 A 361741 D Common Stock 2021-12-23 4 M 0 8476 2.94 A 370217 D Common Stock 2021-12-23 4 S 0 31084 16.9584 D 339133 D Common Stock 2021-12-23 4 G 0 20000 0 D 319133 D Common Stock 2021-12-23 4 G 0 20000 0 D 299133 D Common Stock 2021-12-23 4 G 0 20000 0 D 279133 D Common Stock 20000 I By trust for family member 1 Common Stock 20000 I By trust for family member 2 Common Stock 20000 I By trust for family member 3 Common Stock 2021-12-27 4 M 0 5229 1.45 A 284362 D Common Stock 2021-12-27 4 S 0 5229 16.6360 D 279133 D Stock Option (Right to Buy) 1.45 2021-12-22 4 M 0 22163 0 D 2028-12-11 Common Stock 22163 161337 D Stock Option (Right to Buy) 1.45 2021-12-23 4 M 0 22608 0 D 2028-12-11 Common Stock 22608 138729 D Stock Option (Right to Buy) 2.94 2021-12-23 4 M 0 8476 0 D 2027-12-18 Common Stock 8476 391524 D Stock Option (Right to Buy) 1.45 2021-12-27 4 M 0 5229 0 D 2028-12-11 Common Stock 5229 133500 D The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021, as previously disclosed in the Registrant's Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on November 9, 2021. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $16.50 to $16.60 per share on December 22, 2021. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $16.50 to $17.09 per share on December 23, 2021. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range. On December 23, 2021, the Reporting Person gifted a total of 60,000 shares of Registrant's common stock to three trusts of which the Reporting Person's immediate family members are the sole trustees and sole beneficiaries. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $16.50 to $16.85 per share on December 27, 2021. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range. This option was granted on December 12, 2018 and vests as follows: (1) no shares underlying the option shall vest unless, for a period of twenty consecutive trading days, the average closing sale price of the Registrant's common stock is equal to or exceeds 125% of the exercise price per share of such option (the "Performance Condition"), (2) subject to satisfaction of the Performance Condition, the option shall vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date, and (3) such stock options shall be subject to "double-trigger" acceleration of vesting upon termination of employment following a change of control in the Registrant. This option was granted on December 19, 2017 and vests with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date. /s/ Todd Anderman, as Attorney-in-Fact for Glenn P. Sblendorio 2021-12-27